Search results
Found 7365 matches for
Today University of Oxford and AstraZeneca researchers present a pooled analysis of Phase 3 trials of a vaccine against SARS-CoV-2 across two different dose regimens, resulting in an average efficacy of 70.4%.
MLSTF Summer 2024 - Minutes
Minutes from MLSTF 2024 Panel meeting
Guidance For Applicants FA Alliance Catalyst
Guidance For Applicants